This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Poxel. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Saoussen Wacharine-Antar: Innovator in Enantiomeric Separation
Introduction
Saoussen Wacharine-Antar is a prominent inventor based in Menzel Bouzelfa, Tunisia. She has made significant contributions to the field of chemistry, particularly in the area of enantiomeric separation. Her innovative work aims to address critical health issues associated with insulin-resistance syndrome.
Latest Patents
Wacharine-Antar holds a patent for a process titled "Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization." This groundbreaking process focuses on the enantiomeric separation of racemic 3,6-dihydro-1,3,5-triazine derivatives. The method utilizes preferential crystallization to enhance the treatment of disorders linked to insulin-resistance syndrome.
Career Highlights
Currently, Saoussen Wacharine-Antar is associated with Poxel, a company dedicated to developing innovative treatments for metabolic diseases. Her work at Poxel reflects her commitment to advancing medical science and improving patient outcomes.
Collaborations
Wacharine-Antar collaborates with esteemed colleagues, including Matthias Helmreich and Gérard Coquerel. These partnerships enhance her research and contribute to the development of effective solutions in her field.
Conclusion
Saoussen Wacharine-Antar is a trailblazer in the realm of enantiomeric separation, with a focus on improving treatments for insulin-resistance syndrome. Her innovative patent and work at Poxel underscore her dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile